Medical News

RSS

New Jersey District Court denies Teva's motion to overturn jury verdict in generic Protonix litigation

Teva Pharmaceutical Industries Ltd. announced today that the U.S. District Court for the District of New Jersey denied Teva's motion to overturn an April 23, 2010, jury verdict finding the patent in suit not invalid. The Court also denied Wyeth and Nycomed's request for FDA to reset the date of Teva's final approval to January 2011, based on the fact that Teva has patent defenses remaining at the District Court, including patent misuse.

17 Jul 2010

GOP wants to know if Supreme Court nominee Kagan would recuse herself from health reform case

Republicans on the Senate Judiciary Committee want more information on if Supreme Court nominee Elena Kagan would recuse herself from considering a health reform case because of her involvement with the Obama administration.

17 Jul 2010

CCTP focuses on identifying, testing drugs for cancer stem cell treatment

Cancer and stem cell biology researchers at the University of Colorado are launching the nation's first program focused on identifying and testing drugs that target and destroy cells thought to be at the root of cancer-cancer stem cells (CSCs).The Cancer Stem Cell-Directed Clinical Trials Program (CCTP) is a collaboration between the University of Colorado Cancer Center and the Charles C. Gates Center for Regenerative Medicine and Stem Cell Biology, both located at the University of Colorado School of Medicine.

17 Jul 2010

Maxygen's option and licensing arrangement with Cangene expires

Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.

17 Jul 2010

Medicaid directors worried over expansion, Indiana's says federal government is not giving enough guidance

The new health law calls for dramatic increase in Medicaid programs, the joint federal-state health coverage for low-income residents. Some state Medicaid directors say they are worried about how that expansion will work and some are complaining that they are not getting enough guidance from federal officials.

17 Jul 2010

DOJ-HHS Medicare Fraud Strike Force charges 94 people for $251 million in false claims

Ninety-four people have been charged for their alleged participation in schemes to collectively submit more than $251 million in false claims to the Medicare program in the continuing operation of the Medicare Fraud Strike Force in Miami; Baton Rouge, La.; Brooklyn, N.Y.; Detroit and Houston, announced Attorney General Eric Holder, Department of Health and Human Services (HHS) Secretary Kathleen Sebelius, FBI Director Robert Mueller and Daniel R. Levinson, Inspector General of HHS.

17 Jul 2010

AMPK may regulate epigenetic mechanism: Research

AMP-activated protein kinase, or AMPK, is a master regulator protein of metabolism that is conserved from yeast to humans. When a cell is low on fuel, AMPK shuts down processes that use energy and turns on processes that produce energy.Biologists have been studying how AMPK works for several decades and know that once it is activated, AMPK turns on a large number of genes by passing the "make more energy" message through numerous signaling cascades in the cell. What was not known, until now, was that AMPK also works via an epigenetic mechanism to slow down or stop cell growth.

17 Jul 2010

New Hampshire launches accountable care pilot ahead of schedule

Five separate groups of New Hampshire hospitals and other health care providers are forming "accountable care organizations" as part of a pilot program intended to keep patients healthy and costs down, Bloomberg Businessweek reports. The program "attempts to tackle what many consider to be a big problem in the current system: having accountability spread across hospitals, doctors' offices, insurance carriers and employers with no one group responsible for the overall management of care."

17 Jul 2010

New microfluidic device for effective HIV diagnosis

UC Davis biomedical engineer Prof. Alexander Revzin has developed a "lab on a chip" device for HIV testing. Revzin's microfluidic device uses antibodies to "capture" white blood cells called T cells that are affected by HIV. In addition to physically binding these cells the test detects the types and levels of inflammatory proteins (cytokines) released by the cells.

17 Jul 2010

JANA Partners sends detailed critique of Charles River's revised investor presentation on WuXi acquisition

JANA Partners LLC today sent Charles River Laboratories International, Inc. a detailed critique of Charles River's revised investor presentation released earlier this week, in which Charles River once again seeks to persuade shareholders of the merits of its proposed acquisition of WuXi PharmaTech (Cayman) Inc..

17 Jul 2010

BioRadar develops TransFMDV for Foot and Mouth Disease

BioRadar UK Ltd. predicted one year ago the current severe Foot and Mouth Disease (FMD) outbreaks after recording an increase of the Replikin Count (ref. 1) of the FMD Virus (FMDV) to its highest level in 52 years. Based on these findings, a new synthetic Replikins Trans-Strain FMD Vaccine, called TransFMDV(TM), has been developed and is now available. The announcement was made at the recent Biorbis Conference on Vaccine Production and Manufacturing in Amsterdam, the Netherlands. The conference was attended by major pharmaceutical company executives to examine how vaccine production could be accelerated in view of the problem last year of responding "too little, too late" to the H1N1 influenza pandemic.

17 Jul 2010

InformedDNA named finalist for Best Practices in Health Care Consumer Empowerment and Protection Awards

Informed Medical Decisions, Inc. (InformedDNA) has been selected as one of 30 finalists for the Best Practices in Health Care Consumer Empowerment and Protection Awards. URAC, the nation's leading accreditation organization, will honor the finalists during their 11th Annual Quality Summit, October 5-7, 2010 in Chicago, IL.

17 Jul 2010

Roper's Senior Subordinated Convertible Notes due 2034 to accrue contingent interest

Roper Industries, Inc. announced today that its Senior Subordinated Convertible Notes due 2034 will accrue contingent interest for the period of July 16, 2010 to January 15, 2011 at an annual rate of 0.25% of the average market price of the Notes for the five trading days ended July 13, 2010.

17 Jul 2010

Proton therapy treatment for anal canal cancer performed for first time in US

The INTEGRIS Cancer Institute of Oklahoma and the ProCure Proton Therapy Center announce a breakthrough treatment approach for anal canal cancer. For the first time in the United States proton therapy is now being used to treat this type of cancer.

17 Jul 2010

Ingen files patent to produce new drug insulin thermos product

Ingen Technologies, Inc. (Pink Sheets:IGNT), an emerging medical device manufacturer developing innovative solutions for the respiratory market, with a new patented and proprietary medical product line targeting the $8B respiratory market, announced today that the company has also filed a U.S patent and will begin the required manufacturing processes to produce the new drug insulin thermos product.

17 Jul 2010

NCOA adds ILS as partner to sponsor Private Label version of online screening service for senior benefits

The National Council on Aging (NCOA) today announced the addition of Independent Living Systems (ILS) as the newest partner to sponsor a Private Label version of BenefitsCheckUp, NCOA's online screening service for senior benefits. The Private Label version of BenefitsCheckUp will allow ILS to enhance the care management services the company currently provides to its clients, many of whom are frail and underprivileged individuals who require chronic care or other special needs.

17 Jul 2010

Christiana Care ranked among top 50 of America's best hospitals in 2 specialties

In its annual Best Hospitals edition, US News & World Report places Christiana Care among the top 50 listings in 2 specialties – Gastroenterology and Urology.

17 Jul 2010

Florida Institute of Technology assists licensing CDNI-Glu compound to UK company

As a national research university, Florida Institute of Technology not only involves its students in research, but also seeks to license and patent its many innovations. An example of recently licensed university technology is a chemical compound that facilitates the work of neuroscientists in the laboratory.Associate Professor Nasri Nesnas was familiar as a chemist with the chemical compound CDNI-Glu, a commonly used laboratory research tool. Most often, neuroscientists use it to study the brain's neural networks by improving the localization of synaptic stimulation

17 Jul 2010

IAS announces winners of four scientific awards to be presented at AIDS 2010

The International AIDS Society (IAS) announced today the ten winners of four prestigious scientific awards, to be presented at plenary sessions during the XVIII International AIDS Conference (AIDS 2010). Presented by the IAS and partners, these awards recognize scientists involved in innovative HIV and AIDS research throughout the world. "The quality of work represented by the 2010 awardees is remarkable," said IAS President Julio Montaner. "The IAS hopes to draw the world's attention to these individuals and to their significant scientific accomplishments, as well as to the continued need for innovation in all of the major areas of HIV and AIDS research, represented by the six conference programme tracks."

17 Jul 2010

Resveratrol concentration impacts cancer risk mitigation: Study

Agricultural Research Service (ARS) chemist Thomas Wang, who specializes in cancer prevention research, has reported evidence that for some dietary compounds, length of exposure over time may be key to whether or not ingestion leads to a beneficial, or detrimental, effect.Scientists do not know exactly why one person develops cancer and another does not. But they do know that certain nutrients might increase or decrease cancer risk. There are "layers" of factors involved in the development of cancer, and Wang is studying the layers involving peoples' diet complexity and gene expression.

17 Jul 2010

Medical News

New Jersey District Court denies Teva's motion to overturn jury verdict in generic Protonix litigation

GOP wants to know if Supreme Court nominee Kagan would recuse herself from health reform case

CCTP focuses on identifying, testing drugs for cancer stem cell treatment

Maxygen's option and licensing arrangement with Cangene expires

Medicaid directors worried over expansion, Indiana's says federal government is not giving enough guidance

DOJ-HHS Medicare Fraud Strike Force charges 94 people for $251 million in false claims

AMPK may regulate epigenetic mechanism: Research

New Hampshire launches accountable care pilot ahead of schedule

New microfluidic device for effective HIV diagnosis

JANA Partners sends detailed critique of Charles River's revised investor presentation on WuXi acquisition

BioRadar develops TransFMDV for Foot and Mouth Disease

InformedDNA named finalist for Best Practices in Health Care Consumer Empowerment and Protection Awards

Roper's Senior Subordinated Convertible Notes due 2034 to accrue contingent interest

Proton therapy treatment for anal canal cancer performed for first time in US

Ingen files patent to produce new drug insulin thermos product

NCOA adds ILS as partner to sponsor Private Label version of online screening service for senior benefits

Christiana Care ranked among top 50 of America's best hospitals in 2 specialties

Florida Institute of Technology assists licensing CDNI-Glu compound to UK company

IAS announces winners of four scientific awards to be presented at AIDS 2010

Resveratrol concentration impacts cancer risk mitigation: Study

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News